Target intelligence / Profile preview

Cyclin D1 protein (Cyclin D1)

Target
Cyclin D1
Molecular classification
Cell cycle regulator, Regulatory subunit of cyclin-dependent kinase (CDK) complex, Other (Cyclin family protein)
01

Overview

Cyclin D1 is a regulatory subunit belonging to the highly conserved cyclin family. It forms complexes with cyclin-dependent kinases 4 and 6 (CDK4/6), which are essential for driving the transition from G1 to S phase during the eukaryotic cell cycle. The Cyclin D–CDK4/6 holoenzyme phosphorylates members of the retinoblastoma tumor suppressor family—including pRb—leading to their functional inhibition and allowing progression through the restriction point into DNA synthesis. Dysregulation—through gene amplification or overexpression—of Cyclin D1 is frequently observed in various human cancers such as breast carcinoma and mantle cell lymphoma; it plays a pivotal role in oncogenesis by promoting uncontrolled cellular proliferation. Beyond its canonical role as a CDK regulator, Cyclin D1 also modulates transcription factor activity and influences processes like metabolism and migration. Clinically relevant drugs such as palbociclib inhibit this pathway by targeting associated kinases. Immunohistochemical detection serves as a diagnostic biomarker for certain lymphomas.

Other names
CCND1G1/S-specific cyclin-D1BCL1 (historical, in context of chromosomal translocation)PRAD1 (parathyroid adenomatosis 1)
02

Mechanism of action

Inhibition of CDK4/6 activity to block phosphorylation/inactivation of retinoblastoma protein and arrest cell cycle at G1 phase

03

Biological functions

Regulation of cell cycle progression, especially G1/S transitionPhosphorylation and inhibition of retinoblastoma protein (pRb)Regulation of transcription factors and chromatin remodeling proteinsControl of cellular metabolism, differentiation, migration, and angiogenesis
04

Disease associations

Cancer (notably breast cancer, mantle cell lymphoma, parathyroid adenoma, colon cancer, melanoma, prostate cancer)Tumorigenesis via gene amplification or overexpression
05

Safety considerations

Myelosuppression/neutropenia with CDK4/6 inhibitors due to effects on proliferating cellsPotential for off-target effects impacting normal tissue proliferation
06

Interacting drugs

Palbociclib

2 more in the full profile.

07

Biomarkers

Overexpression or amplification used as a biomarker in mantle cell lymphoma diagnosis

Beyond the preview

Go deeper on Cyclin D1 protein (Cyclin D1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin D1 protein (Cyclin D1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call